OCT-1002

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameOCT-1002
Drug Alias NameOCT-1001 prodrughypoxia activated prodrug (OncoTherics)topoisomerase II inhibitor (OncoTherics)OCT-1002
ClassificationSmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsProstatic NeoplasmsPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoTherics
China Registration ClassN/A

Develop Information

Active CompaniesOncoTherics
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsPancreatic NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A